跳至主要内容
临床试验/CTRI/2024/10/075488
CTRI/2024/10/075488尚未招募4 期

Efficacy and safety of recommended dose of albumin infusion vs. low dose albumin infusion in patients of decompensated cirrhosis with Acute Kidney Injury

Govind Ballabh Pant Institute of Postgraduate Medical Education And Research1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年11月1日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
The proportion of decompensated cirrhosis patients having acute kidney injury with complete resolution

研究概览

简要总结

Ours is a Open labelled Randomized controlled trial in which we aim to compare the efficacy and safety of 20% human albumin infusion at a dose of 1gm/kg body weight daily (maximum dose 100gm) with albumin infusion at a dose of 0.5 gm/kg body weight (maximum dose 40gm) in patients with decompensated cirrhosis having acute kidney injury.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed cases of decompensated cirrhosis with Acute kidney injury ≥Stage IB i.e. Serum creatinine ≥1.5mg/dl.

排除标准

  • Pregnancy Advanced Chronic Kidney Disease Shock Prior Kidney or Liver Transplant Acute or chronic Renal Replacement Therapy at the time of enrolment Congestive heart failure ï‚· Known allergy or develops allergic reaction to human albumin.

结局指标

主要结局

The proportion of decompensated cirrhosis patients having acute kidney injury with complete resolution

时间窗: After 2 consecutive days of fluid challenge with 20% human albumin at a dose of – | 1gm/kg of body weight daily | 0.5gm/kg of body weight daily

(S. Cr. within 0.3mg/dl of Baseline S. Creatinine) of acute kidney injury after 2 consecutive days of fluid

时间窗: After 2 consecutive days of fluid challenge with 20% human albumin at a dose of – | 1gm/kg of body weight daily | 0.5gm/kg of body weight daily

challenge with 20% human albumin at a dose of –

时间窗: After 2 consecutive days of fluid challenge with 20% human albumin at a dose of – | 1gm/kg of body weight daily | 0.5gm/kg of body weight daily

1gm/kg of body weight daily;

时间窗: After 2 consecutive days of fluid challenge with 20% human albumin at a dose of – | 1gm/kg of body weight daily | 0.5gm/kg of body weight daily

0.5gm/kg of body weight daily

时间窗: After 2 consecutive days of fluid challenge with 20% human albumin at a dose of – | 1gm/kg of body weight daily | 0.5gm/kg of body weight daily

次要结局

  • Frequency of adverse events among patients treated with 20% human albumin at a dose of-(1gm/kg of body weight daily;)

研究者

发起方
Govind Ballabh Pant Institute of Postgraduate Medical Education And Research
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Aman Agrawal

Delhi University

研究点 (1)

Loading locations...

相似试验